Nutra Pharma Corp.
Bringing Healthcare Solutions to the World
 
Corporate Overview
Overview
Management Team
Board of Directors
Social Responsibility
NPC Blog
Presentations
Code of Ethics
Drug Development
R&D Pipeline
Nutra Pharma is developing an innovative pipeline of biopharmaceutical products
E-Alerts
Signup to receive news and announcements from Nutra Pharma:
First Name:
Last Name:
Email:
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.

CORPORATE COMMUNICATIONS POLICY

As a public company, Nutra Pharma Corporation (including its subsidiaries or affiliates that it controls or is under common control with (the “Company”) has an obligation to its shareholders to ensure that all material information disseminated to the public is factual, accurate, and in
compliance with all applicable state and federal securities laws, including Regulation Fair Disclosure (“Reg FD”), state and federal anti-fraud and anti-manipulation rules and securities laws applicable to insider trading.

In September 2010, Nutra Pharma's board of directors adopted the following Corporate Communications Policy:

Download PDF (111kb)

 
Quick Nav
Nyloxin // Chronic Pain Relief
Read about Jeff Gottfurcht, the first rheumatoid arthritis sufferer to conquer Everest, in Musculoskeletal Health a special section of the Washington Post.
 

 

 
Recent News
 
September 14, 2016
Nutra Pharma Announces Manufacturing Alliance with Omnia Biologics to Produce RPI-78M for Clinical Trials in Pediatric Multiple Sclerosis


August 30, 2016
Nutra Pharma Announces Addition of Maj. Gen. Kenneth Dowd to its Advisory Board


August 16, 2016
Nutra Pharma Announces Additions to the Board of Directors and Management Team


 
 
Announcements
Click here to view a Letter to Shareholders from the Company's CEO, Rik J Deitsch.
 
 
Facebook   Twitter
 
NPC
Privacy Policy Code of Ethics